EDUCATION: Sees 500 Inventions in 2020
Research, innovation and entrepreneurship remains strong at the University of California San Diego (UCSD), which continues to produce new startups at a high rate.
FINANCE: Co. Raised $190M to Expand its Geographic Footprint, Adds Partner
Anzu Partners, San Diego’s fourth largest venture capital firm, has added a partner from the international investment banking sector.
BIOTECH: Fast, Serial COVID-19 Testing Can Help Reopening Effort
Becton, Dickinson and Company, a global medical technology company also known as BD, has developed the BD Veritor System for Rapid Detection of SARS‑CoV‑2 which can provide results in as little as 15 minutes.
BIOTECH: Annual Revenue Up $451 Million
Dexcom Inc. expects to crack the $2 billion mark when it is time to report revenue for 2021.
BIOTECH: Codex DNA Hopes It Will Accelerate Innovation of Therapies and Vaccines
Codex DNA released the world’s first full-length synthetic genomes of the SARS-CoV-2 variants with the goal of helping researchers develop the life-saving therapies and vaccines needed to tackle the coronavirus pandemic.
BIOTECH: Antibody-Centric Company Grows
Sorrento Therapeutics (NASDAQ: SRNE) will acquire ACEA Therapeutics in a deal that offers ACEA’s equity holders approximately $38 million in common stock, the company announced on April 5.
BIOTECH: Medical Device Maker's Rise Influenced by COVID-19
ResMed Inc. (Nasdaq: RMD), which offers technology to help people breathe better and connect them to their caregivers, grew its net income by $18.9 million in its second quarter, which ended Dec. 31.
HEALTHCARE: Hospital Wins Best of Show and Earns More Than Any Other Regional Institution
Oceanside’s Tri-City Medical Center was honored recently with 18 awards from the Health Care Communicators of Southern California for community outreach and its public engagement efforts.
BIOTECH: 2021 Could Be Turning Point as Grail Matter Is Decided
Illumina Inc. (Nasdaq: ILMN) expects a $4 billion year in 2021. The gene sequencing specialist increased its financial guidance on April 5, saying it expects year-over-year revenue growth of 25% to 28% from the $3.24 billion that it brought in during fiscal 2020.
LIFE SCIENCE: Co. Collaborating With Emory
Exagen Inc. (Nasdaq: XGN), a commercial-stage life science company, is joining forces with Emory University to conduct a new study on the long-term effects of COVID-19 infection in the development of autoimmune diseases.
CONSTRUCTION: From Industrial to Biotech, Co. Makes Magic Happen
In recent years, San Diego has seen big increases in venture capital investment, and booming construction of new lab spaces around the region. Burger Construction has made a name for itself as one of the leading construction firms for the life science industry — having recently completed projects for Cue Health and GenMark.
REAL ESTATE: Area Sees Strong Demand
Longfellow Real Estate Partners has acquired a Sorrento Mesa business park, bringing the company’s San Diego holdings to more than a million square feet.
STARTUP: Co. Prepares for Scale and Growth
Carlsbad-based Iridia has raised $24 million to build the world’s first high-density DNA-Based memory chip.
PHARMA: IPO Shows Broader Opportunity in Life Science Market
CONSTRUCTION: Overcomes Permit Delays and Special Requirements
Construction of a UTC fertility clinic turned into “the poster child” for trying to build something in the midst of the COVID-19 pandemic.